Search

everythinglearnresearchcommunity

for

Search:↓

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

IL-18 signaling helps mature Tregs move into the thymus.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

CXCR2 in skin cells promotes tumor growth.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

Hair follicles produce IL-7, which is essential for certain skin lymphoma cells to survive.

Inactivating both p53 and Rb genes in mice speeds up aggressive skin cancer development.

LGD1069 effectively prevents breast tumors in mice without toxicity.

TCDD disrupts skin stem cells, causing skin issues like chloracne.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Blocking interferon-gamma might help treat various autoimmune diseases.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Isotretinoin shows promise as a treatment for Chagas disease by effectively inhibiting key transporters in the parasite.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.

Tgm2 helps stabilize dying cells and aids fibroblast attachment to the extracellular matrix.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Removing both Atr and Trp53 genes in adult mice causes severe tissue damage and death due to DNA damage.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

The assay effectively identifies compounds that affect immune cell activation.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

Enhancing immune response can improve cancer treatment effectiveness.